CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Dec 02, 2024. (Total: 6432 publications)

All Cancer Diabetes Economic Equity Environmental FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Records 1-8 (of 8 Records)

Query Trace: Shcherbik S[original query]
Development of an RNA strand-specific hybridization assay to differentiate replicating versus non-replicating influenza A virus. Yang G , Hodges EN , Winter J , Zanders N , Shcherbik S , Bousse T , Murray JR , Muraduzzaman AKM , Rahman M , Alamgir ASM , Sabrina Flora M , Blanton L , Barnes JR , Wentworth DE , Davis CT . J Clin Microbiol 2020 58 (6)
Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model. Korenkov DA , Laurie KL , Reading PC , Carolan LA , Chan KF , Isakova Sivak II , Smolonogina TA , Subbarao K , Barr IG , Villanueva J , Shcherbik S , Bousse T , Rudenko LG . Infect Genet Evol 2018 64 95-104
Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein. Rekstin A , Isakova-Sivak I , Petukhova G , Korenkov D , Losev I , Smolonogina T , Tretiak T , Donina S , Shcherbik S , Bousse T , Rudenko L . Biomed Res Int 2017 2017 9359276
Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model. Isakova-Sivak I , Korenkov D , Smolonogina T , Tretiak T , Donina S , Rekstin A , Naykhin A , Shcherbik S , Pearce N , Chen LM , Bousse T , Rudenko L . Virology 2016 500 209-217
Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses. Shcherbik S , Pearce N , Kiseleva I , Larionova N , Rudenko L , Xu X , Wentworth DE , Bousse T . J Virol Methods 2015 227 33-9
Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation. Shcherbik S , Pearce N , Balish A , Jones J , Thor S , Davis CT , Pearce M , Tumpey T , Cureton D , Chen LM , Villanueva J , Bousse TL . PLoS One 2015 10 (9) e0138951
Rapid strategy for screening by pyrosequencing of influenza virus reassortants--candidates for live attenuated vaccines. Shcherbik SV , Pearce NC , Levine ML , Klimov AI , Villanueva JM , Bousse TL . PLoS One 2014 9 (3) e92580
Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production. Shcherbik S , Sergent SB , Davis WG , Shu B , Barnes J , Kiseleva I , Larionova N , Klimov A , Bousse T . J Virol Methods 2014 195 18-25